Ireland
--:--IST
Recruiting Observational

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

NCT06866483 · tracked via the Priya Life Science USA tracker
Sponsor
ZS Associates
Phase
Observational
Started
2025-02-26
Last updated
2025-03-10

Condition(s) studied

Myasthenia GravisNeuromuscular DiseaseNeuromuscular Manifestations

Investigational drug(s) / intervention(s)

Social media recruitmentSelf-AssessmentFollow-up

Social media recruitment: Social media users exposed to a variety of paid social media advertisements as a recruitment tool for study enrollment

Self-Assessment: Eligible participants are asked to complete self-administered physical tests to assess inducible fatigue of specific muscle groups

Follow-up: Patients triaged based on their assessed risk of MG are asked to complete recommended follow-up with a clinician to determine presence of myasthenia gravis

Study summary

This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to seek medical evaluation for suspected myasthenia gravis (MG).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Reside within the 50 states of the United States at the time of enrollment * Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state * Active email account * Fluency in English (spoken / written), as demonstrated by the ability to read and sign the Informed Consent Form Exclusion Criteria: * Live in an overseas territory of the United States * Inability or unwillingness to provide written informed consent * Diagnosed myasthenia gravis, including sero-negative MG\* * Diagnosed multiple sclerosis * Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke

Primary outcome measure(s)

  • Self-Assessment tool validity — 6 months from time of enrollment
    Measure the specificity and sensitivity of the Self-Assessment tool

Trial sites (1)

FacilityCityRegionStatus
ZS Associates Evanston Illinois Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06866483 on ClinicalTrials.gov ↗ ← All trials in the USA